Predictions
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.03
11.11.21
11.11.21
€2.90
11.11.22
11.11.22
-21.78%
28.04.22
28.04.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€11.19
08.11.21
08.11.21
€10.00
08.11.22
08.11.22
-52.24%
14.03.22
14.03.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.17
03.11.21
03.11.21
-
03.11.22
03.11.22
-8.41%
15.11.21
15.11.21
Risky Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€11.11
01.11.21
01.11.21
€10.00
01.11.22
01.11.22
0.67%
08.11.21
08.11.21
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€6.93
01.11.21
01.11.21
€10.80
01.11.22
01.11.22
-21.90%
05.12.21
05.12.21
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.86
27.10.21
27.10.21
€40.00
31.12.23
31.12.23
-59.32%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€30.01
25.10.21
25.10.21
-
25.10.22
25.10.22
-1.37%
31.10.21
31.10.21
Canopy Growth Corp
Start price
Target price
Perf. (%)
€12.28
22.10.21
22.10.21
€19.00
22.10.22
22.10.22
-38.19%
08.01.22
08.01.22
Fennec Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.45
18.10.21
18.10.21
€12.00
31.12.23
31.12.23
-2.68%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Sernova Corp.
Start price
Target price
Perf. (%)
€0.90
13.10.21
13.10.21
€9.20
13.10.24
13.10.24
5.06%
14.06.22
14.06.22
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Undervalued
Very positive Cash Flow expected
Sernova Corp.
Start price
Target price
Perf. (%)
€0.87
13.10.21
13.10.21
€10.00
13.10.24
13.10.24
-4.83%
15.06.22
15.06.22
Leading role in innovation
Capable Management
Good culture
Strong uniques
Sernova Corp.
Start price
Target price
Perf. (%)
€0.88
13.10.21
13.10.21
€7.00
13.10.22
13.10.22
7.44%
14.06.22
14.06.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth > 30% per year expected
Sernova Corp.
Start price
Target price
Perf. (%)
€0.88
13.10.21
13.10.21
€8.50
13.10.22
13.10.22
-1.14%
13.10.21
13.10.21
Leading role in innovation
Capable Management
Good culture
Strong uniques
BELLUS Health Inc.
Start price
Target price
Perf. (%)
€4.95
10.10.21
10.10.21
€8.00
31.12.23
31.12.23
58.11%
13.12.21
13.12.21
Could be very worthwhile Investment >20% year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.49
10.10.21
10.10.21
€5.00
31.12.23
31.12.23
-32.83%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.00
05.10.21
05.10.21
-
05.10.22
05.10.22
-10.00%
08.12.21
08.12.21
Probably not worthwhile Investment
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.40
04.10.21
04.10.21
-
04.10.22
04.10.22
45.45%
10.08.22
10.08.22
Could be worthwhile Investment >10% per year